GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (NAS:IPA) » Definitions » Inventory Turnover

ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Inventory Turnover : 1.23 (As of Jan. 2024)


View and export this data going back to 2011. Start your Free Trial

What is ImmunoPrecise Antibodies Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. ImmunoPrecise Antibodies's Cost of Goods Sold for the three months ended in Jan. 2024 was $2.25 Mil. ImmunoPrecise Antibodies's Average Total Inventories for the quarter that ended in Jan. 2024 was $1.84 Mil. ImmunoPrecise Antibodies's Inventory Turnover for the quarter that ended in Jan. 2024 was 1.23.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. ImmunoPrecise Antibodies's Days Inventory for the three months ended in Jan. 2024 was 74.40.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ImmunoPrecise Antibodies's Inventory-to-Revenue for the quarter that ended in Jan. 2024 was 0.40.


ImmunoPrecise Antibodies Inventory Turnover Historical Data

The historical data trend for ImmunoPrecise Antibodies's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Inventory Turnover Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec13 Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.13 7.26 6.59 5.92 4.81

ImmunoPrecise Antibodies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.18 1.37 1.35 1.23

ImmunoPrecise Antibodies Inventory Turnover Calculation

ImmunoPrecise Antibodies's Inventory Turnover for the fiscal year that ended in Apr. 2023 is calculated as

Inventory Turnover (A: Apr. 2023 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Apr. 2023 ) / ((Total Inventories (A: Apr. 2022 ) + Total Inventories (A: Apr. 2023 )) / count )
=6.751 / ((1.279 + 1.528) / 2 )
=6.751 / 1.4035
=4.81

ImmunoPrecise Antibodies's Inventory Turnover for the quarter that ended in Jan. 2024 is calculated as

Inventory Turnover (Q: Jan. 2024 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Jan. 2024 ) / ((Total Inventories (Q: Oct. 2023 ) + Total Inventories (Q: Jan. 2024 )) / count )
=2.253 / ((1.788 + 1.886) / 2 )
=2.253 / 1.837
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ImmunoPrecise Antibodies  (NAS:IPA) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ImmunoPrecise Antibodies's Days Inventory for the three months ended in Jan. 2024 is calculated as:

Days Inventory =Average Total Inventories (Q: Jan. 2024 )/Cost of Goods Sold (Q: Jan. 2024 )*Days in Period
=1.837/2.253*365 / 4
=74.40

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ImmunoPrecise Antibodies's Inventory to Revenue for the quarter that ended in Jan. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=1.837 / 4.635
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


ImmunoPrecise Antibodies Inventory Turnover Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmunoPrecise Antibodies (ImmunoPrecise Antibodies) Business Description

Traded in Other Exchanges
Address
3204 - 4464 Markham Street, Victoria, BC, CAN, V8Z 7X8
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from Europe.